RENOVORX, INC. Retained Earnings
RENOVORX, INC. (RNXT) had Retained Earnings of -$67.82 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$67.82M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$64.91M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$61.39M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$58.45M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$67.82M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$64.91M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$61.39M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$58.45M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$55.53M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$52.64M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$50.22M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$47.34M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$44.87M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$42.48M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$41.41M 10-K · filed 2025-04-01 |
| 2023-09-30 | -$38.18M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$36.76M 10-Q · filed 2023-08-16 |
| 2023-03-31 | -$34.43M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$31.17M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$29.02M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$26.88M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$24.29M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$21.28M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$18.93M 10-Q · filed 2021-11-15 |
| 2020-12-31 | -$14.96M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |